Moderna shares slip as William Blair cuts rating on valuation after rally
FROM THE WIRE · FINANCE.YAHOO.COM
Investing.com -- Moderna Inc (NASDAQ:MRNA) slid 3% in premarket trading after William Blair downgraded the biotechnology company to Market Perform from Outperform, citing valuation constraints following a meteoric run. The downgrade follows a staggering 545% year-to-date rally…
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bearishThe valuation-based downgrade after a strong rally may weigh on the stock in the short term.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Moderna slid 3% premarket after William Blair downgraded it to Market Perform.
- 02The stock has rallied about 545% year to date.
- 03The analyst says the current share price already prices in an aggressive trajectory.
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
Moderna, Inc.185.65 USD-6.64%today -6.64%Negative Merck & Co., Inc.140.98 USD+0.67%today +0.26%Neutral
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets